Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
32.15
+0.16 (0.48%)
Mar 6, 2025, 11:17 AM EST - Market open
Supernus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 69.33 | 75.05 | 93.12 | 203.43 | 288.64 | Upgrade
|
| Short-Term Investments | 384.28 | 179.82 | 368.21 | 136.25 | 133.89 | Upgrade
|
| Cash & Short-Term Investments | 453.61 | 254.87 | 461.33 | 339.68 | 422.53 | Upgrade
|
| Cash Growth | 77.97% | -44.75% | 35.81% | -19.61% | 21.74% | Upgrade
|
| Receivables | 142.08 | 144.16 | 165.5 | 148.93 | 140.88 | Upgrade
|
| Inventory | 54.29 | 77.41 | 91.54 | 85.96 | 48.33 | Upgrade
|
| Prepaid Expenses | 36.09 | 16.68 | 15.78 | 27.02 | 18.68 | Upgrade
|
| Total Current Assets | 686.07 | 493.11 | 734.15 | 601.59 | 630.42 | Upgrade
|
| Property, Plant & Equipment | 36.02 | 42.52 | 44.08 | 52.32 | 58.06 | Upgrade
|
| Long-Term Investments | - | 16.62 | 93.9 | 119.17 | 350.36 | Upgrade
|
| Goodwill | 117.02 | 117.02 | 117.02 | 117.52 | 77.91 | Upgrade
|
| Other Intangible Assets | 521.91 | 599.89 | 702.46 | 784.69 | 364.34 | Upgrade
|
| Other Long-Term Assets | 7.05 | 8.51 | 10.9 | 13.87 | 23.02 | Upgrade
|
| Total Assets | 1,368 | 1,278 | 1,703 | 1,689 | 1,504 | Upgrade
|
| Accounts Payable | 4.59 | 1.96 | 10.54 | 9.33 | 6.15 | Upgrade
|
| Accrued Expenses | 180.21 | 166.26 | 185.67 | 199.47 | 165.62 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 407.97 | 7.24 | 5.32 | Upgrade
|
| Current Portion of Leases | 6.89 | 8.33 | 6.79 | 6.48 | 7.52 | Upgrade
|
| Other Current Liabilities | 100.72 | 113.64 | 76.99 | 92.86 | 60.5 | Upgrade
|
| Total Current Liabilities | 292.4 | 290.2 | 687.96 | 315.38 | 245.11 | Upgrade
|
| Long-Term Debt | - | - | - | 385.23 | 375.16 | Upgrade
|
| Long-Term Leases | 27.38 | 33.2 | 36 | 41.3 | 48.81 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.96 | 24.96 | 49.81 | 85.36 | 35.22 | Upgrade
|
| Other Long-Term Liabilities | 7.6 | 7.8 | 42.54 | 46.04 | 54.95 | Upgrade
|
| Total Liabilities | 332.34 | 356.16 | 816.3 | 873.3 | 759.24 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 479.44 | 439.49 | 408.12 | 434.34 | 409.33 | Upgrade
|
| Retained Earnings | 556.43 | 482.56 | 481.25 | 379.92 | 326.5 | Upgrade
|
| Comprehensive Income & Other | -0.19 | -0.59 | -3.21 | 1.54 | 8.98 | Upgrade
|
| Shareholders' Equity | 1,036 | 921.52 | 886.2 | 815.85 | 744.86 | Upgrade
|
| Total Liabilities & Equity | 1,368 | 1,278 | 1,703 | 1,689 | 1,504 | Upgrade
|
| Total Debt | 34.27 | 41.53 | 450.76 | 440.25 | 436.82 | Upgrade
|
| Net Cash (Debt) | 419.34 | 229.96 | 104.47 | 18.6 | 336.08 | Upgrade
|
| Net Cash Growth | 82.35% | 120.12% | 461.74% | -94.47% | -37.52% | Upgrade
|
| Net Cash Per Share | 7.49 | 4.14 | 1.69 | 0.34 | 6.26 | Upgrade
|
| Filing Date Shares Outstanding | 55.81 | 54.73 | 54.38 | 53.39 | 52.92 | Upgrade
|
| Total Common Shares Outstanding | 55.74 | 54.72 | 54.25 | 53.26 | 52.87 | Upgrade
|
| Working Capital | 393.67 | 202.92 | 46.19 | 286.21 | 385.31 | Upgrade
|
| Book Value Per Share | 18.58 | 16.84 | 16.33 | 15.32 | 14.09 | Upgrade
|
| Tangible Book Value | 396.8 | 204.61 | 66.72 | -86.36 | 302.61 | Upgrade
|
| Tangible Book Value Per Share | 7.12 | 3.74 | 1.23 | -1.62 | 5.72 | Upgrade
|
| Machinery | 14.48 | 14.03 | 13.11 | 14.23 | 14.64 | Upgrade
|
| Construction In Progress | - | - | 0.21 | 0.03 | - | Upgrade
|
| Leasehold Improvements | 14.02 | 14.02 | 14.02 | 14.37 | 15.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.